Wolf,
<A second possible issue is the need to ramp-up the Canadian market direct effort. This should really start months priorto actually getting approval since it involves marketing and
sales detailed strategies, hiring, development of training
and literature materials, physical office space, furniture,
contact research, advertising, etc, etc, to various degrees
to "hit the ground running".>
Wolf, I agree with this completely. So the question I have for you is this:
If UK approval is imminent why has Dimethaid not been able to execute an agreement with a marketing partner months ago that provides an upfront cash payment to help pay for production and commence pre-commercialization marketing activities?????
Given that Dimethaid has commenced production, they clearly demonstrated their commitment to having the product ready. You have to believe that Dimethaid's preference would have been to sign a UK partner up months ago to do all the activities you outlined.
Let me present some possible theories...
Rebecca has demanded such a high royalties for Dimethaid, that every company has said, OK if that's the deal, you deliver approval and then we'll talk. With her antagonistic style, she may have pi**ed a few off which has limited Dimethaid to only one or two qualified companies and reduced her negotiating leverage.
Maybe as I suggested yesterday, approval in not imminent?
There has to be a reason and maybe we need to consider theories that none off us likes to think about.
There is something not right here and we need to try and figure out what.
John |
